Literature DB >> 10535707

Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.

M A Forget1, R R Desrosiers, R Béliveau.   

Abstract

Physiological processes involving remodelling of the extracellular matrix, such as wound healing, embryogenesis, angiogenesis, and the female reproductive cycle, require the activity of matrix metalloproteinases (MMPs). This group of proteases degrades basal membranes and connective tissues and plays an essential role in the homeostasis of the extracellular matrix. An imbalance in the expression or activity of MMPs can have important consequences in diseases such as multiple sclerosis, Alzheimer's disease, or the development of cancers. Because of the pathophysiological importance of MMPs, their activity is highly controlled in order to confine them to specific areas. An activation cascade, initiated by the proteolysis of plasminogen, cleaves proMMPs, and every step is controlled by specific activators or inhibitors. MMPs destabilize the organization of the extracellular matrix and influence the development of cancer by contributing to cell migration, tumor cell proliferation, and angiogenesis. Accordingly, these proteases possess an important role in cell-matrix interactions by affecting fundamental processes such as cell differentiation and proliferation. Therefore, the characterization of MMPs involved in specific types and stages of tumors will significantly improve the diagnosis and treatment of these cancers in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535707

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  30 in total

1.  Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.

Authors:  B Annabi; A Pilorget; N Bousquet-Gagnon; D Gingras; R Béliveau
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

2.  Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells.

Authors:  Guogang Yuan; Lu Qian; Lun Song; Ming Shi; Dan Li; Ming Yu; Meiru Hu; Beifen Shen; Ning Guo
Journal:  Mol Cell Biochem       Date:  2008-07-04       Impact factor: 3.396

3.  Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil: role of COL1A1.

Authors:  Lucas Almeida; Joyce Oliveira; Luiz Henrique Guimarães; Edgar M Carvalho; Jenefer M Blackwell; Léa Castellucci
Journal:  Infect Genet Evol       Date:  2015-01-03       Impact factor: 3.342

4.  Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways.

Authors:  Sarah K Baird; Laura Allan; Christoph Renner; Fiona E Scott; Andrew M Scott
Journal:  Clin Exp Metastasis       Date:  2015-05-21       Impact factor: 5.150

5.  Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of breast cancer.

Authors:  P Chiranjeevi; K Mrudula Spurthi; N Santhoshi Rani; G Rajesh Kumar; T Mohini Aiyengar; M Saraswati; G Srilatha; G Kishore Kumar; Sudha Sinha; C Sanjeeva Kumari; B Nagarjuna Reddy; S Vishnupriya; H Surekha Rani
Journal:  Tumour Biol       Date:  2013-12-20

6.  Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.

Authors:  Abdullah Karadag; Neal S Fedarko; Larry W Fisher
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

7.  Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan.

Authors:  Mitsushige Sugimoto; Takahisa Furuta; Chise Kodaira; Masafumi Nishino; Mihoko Yamade; Mutsuhiro Ikuma; Haruhiko Sugimura; Akira Hishida
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

8.  Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines.

Authors:  Andrea Schröpfer; Ulrike Kammerer; Michaela Kapp; Johannes Dietl; Sonja Feix; Jelena Anacker
Journal:  BMC Cancer       Date:  2010-10-13       Impact factor: 4.430

Review 9.  Brain endothelial cells as pharmacological targets in brain tumors.

Authors:  Michel Demeule; Anthony Régina; Borhane Annabi; Yanick Bertrand; Michel W Bojanowski; Richard Béliveau
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

10.  Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature.

Authors:  Andrea Köhrmann; Ulrike Kammerer; Michaela Kapp; Johannes Dietl; Jelena Anacker
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.